Konica Minolta Precision Medicine to Present on the Future of Integrated Diagnostics at AWS Healthcare & Life Science Virtual Symposium
Tom Schoenherr, CEO of Ambry Genetics, Introduces the LATTICE™ Platform
News provided by
Share this article
Share this article
ALISO VIEJO, Calif., May 27, 2021 /PRNewswire/ Konica Minolta Precision Medicine (KMPM), announced today that Tom Schoenherr, Chief Executive Officer of Ambry Genetics, a KMPM company, will present at the third annual AWS Healthcare & Life Science Virtual Symposium on Thursday, May 27, 2021.
The presentation will introduce the LATTICE™ platform, a groundbreaking integrated diagnostic data platform combining genomics, pathology, radiology data, and other critical information to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests. LATTICE leverages machine learning services by combining KMPM s cutting-edge science with the added power of AWS to accelerate drug discovery an